Amyris Inc. made an agreement with Swiss company Givaudan to develop an ingredient for perfumes.
Givaudan is based in Vernier, Switzerland. It will use Amyris’ product “Biofene” (farnesene) for perfume products that could be created as early as 2012.
Emeryville-based Amyris (NASDAQ: AMRS) didn’t give financial details of this deal.
No comments:
Post a Comment